Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Jefferies Spinoff Vitesse Energy Undervalued

Por: Forbes Business February 15, 2023

thumbnail

Photographer: Jeenah Moon/Bloomberg© 2021 Bloomberg Finance LP On February 14, 2023, Vitesse Energy Inc. (NYSE: VTS, $18.69, Market Capitalization: $527.1 million) announced FY22 results. Total revenue grew 55.0% YoY to $300.1 million and was driven by growth in Oil and Natural gas segments. Oil segment revenue increased by 53.0% YoY to $242.5 million. Natural Gas revenue increased 64.0% YoY to $57.6 million, whereas adjusted EBITDA grew by... + full article



Similar News

This stock-market sentiment gauge hit a level not seen in over 2 years. But Jefferies says it isn't a 'golden indicator' to the upside.

MarketWatch USA Business July 24, 2023

thumbnailBut a strategist at Jefferies thinks the survey isn’t a “golden indicator” of stock-market upside, and argues it also hasn’t always translated to solid performance. Optimism in the stock market increased 10.4 percentage points to 51.4%, reaching the highest level since... + más

'Frustration' fuels Broncos' sideline blowup in loss | ESPN

'Frustration' fuels Denver Broncos' sideline blowup in loss | ABC News


This stock-market sentiment gauge hit a level not seen in over 2 years. But Jefferies says it isn't a 'golden indicator' to the upside.

MarketWatch USA Business July 24, 2023

thumbnailBut a strategist at Jefferies thinks the survey isn’t a “golden indicator” of stock-market upside, and argues it also hasn’t always translated to solid performance. Optimism in the stock market increased 10.4 percentage points to 51.4%, reaching the highest level since... + más

'Frustration' fuels Broncos' sideline blowup in loss | ESPN

'Frustration' fuels Denver Broncos' sideline blowup in loss | ABC News


This stock-market sentiment gauge hit a level not seen in over 2 years. But Jefferies says it isn't a 'golden indicator' to the upside.

MarketWatch USA Politics July 24, 2023

thumbnailBut a strategist at Jefferies thinks the survey isn’t a “golden indicator” of stock-market upside, and argues it also hasn’t always translated to solid performance. Optimism in the stock market increased 10.4 percentage points to 51.4%, reaching the highest level since... + más

'Frustration' fuels Broncos' sideline blowup in loss | ESPN

'Frustration' fuels Denver Broncos' sideline blowup in loss | ABC News


Meta Stock and Other Industry-Specific Value Plays

MarketWatch USA Business February 28, 2023

thumbnail“Traditional value investing needs to evolve,” Desh Peramunetilleke, global head of microstrategy at Jefferies, wrote in a note Monday, noting that it isn’t enough to simply say a company is undervalued. Investors should know if a company is undervalued by the most... + más

NFL Playoff Scenarios | ABC News

Le Krewe du Roi celebrates the state at 58th annual Mardi Gras Ball | The Advocate


18 stock picks in a 'Goldilocks' scenario for U.S. consumers

MarketWatch USA Business January 11, 2023

thumbnailAnd now, analysts at Jefferies have lifted the sector to a “bullish” rating. In a note to clients on Jan. 10, Jefferies’ global equity strategist, Sean Darby, wrote: “A Goldilocks scenario might be unfolding for the U.S. consumer — falling inflation but steady... + más

'Frustration' fuels Broncos' sideline blowup in loss | ESPN

Healthy Mayfield 'rolling with the punches' as QB2 | ESPN


Bride stops entire ceremony when she forgets part of her wedding dress

New York Post USA Life November 01, 2022

thumbnailThings started out a little rocky for one bride on her wedding day.  Becky Jefferies had just walked down the aisle in Greece for her long-awaited ceremony when she had a sudden epiphany: She was missing part of her wedding dress.  The two-piece dress had a detachable skirt... + más

Teen's parents mull charges against hateful bride over dress debacle | Newsweek

Family passes down $100 wedding dress for 72 years | ABC News


FDA Imposes Partial Hold On DBV Technologies' Phase III VITESSE Study

RTTNews USA Health September 24, 2022

thumbnailDBV Technologies' () phase III study of modified Viaskin Peanut 250 µg patch, dubbed VITESSE, has been slapped with a partial clinical hold by the FDA.VITESSE is a phase III, double-blind, placebo-controlled, randomized study to assess the efficacy and safety of... + más

ALS drug wins FDA approval despite questionable data | ABC News

ALS drug wins FDA approval despite questionable data | WPLG Local 10



About iurex | Privacy Policy | Disclaimer |